These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 704919)

  • 1. The effects of 11-methyl 16,16 dimethyl prostaglandin E2 on gastric acid secretion in man.
    Wilson DE; Winter SL
    Prostaglandins; 1978 Jul; 16(1):127-33. PubMed ID: 704919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 11-methyl 16,16 dimethyl prostaglandin E2 on canine gastric acid secretion.
    Wilson DE; Chang IW; Paulsrud J; Holland G
    Prostaglandins; 1978 Jul; 16(1):121-6. PubMed ID: 704918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients.
    Peterson W; Feldman M; Taylor I; Bremer M
    Dig Dis Sci; 1979 May; 24(5):381-4. PubMed ID: 456224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers.
    Konturek SJ; Swierczek JS; Kwiecien N; Obtułowicz W; Sito E; Oleksy J
    Scand J Gastroenterol; 1979; 14(7):813-9. PubMed ID: 395627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of stimulated gastric secretion by an orally administered prostaglandin capsule. A study in normal men.
    Wilson DE; Quertermus J; Raiser M; Curran J; Robért A
    Ann Intern Med; 1976 Jun; 84(6):688-91. PubMed ID: 779562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients.
    Ippoliti AF; Isenberg JI; Hagie L
    Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of 15(R)15 methyl prostaglandin E2 and the interaction with atropine on stimulated gastric acid secretion in man.
    Kollberg B; Johansson C
    Scand J Gastroenterol; 1979; 14(3):337-42. PubMed ID: 375376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.
    Robert A; Kane G; Reele SB
    Gut; 1981 Sep; 22(9):728-31. PubMed ID: 7297921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl-prostaglandin E2 analogues for healing of gastro-duodenal ulcers.
    Rybicka J; Gibiński K
    Scand J Gastroenterol; 1978; 13(2):155-9. PubMed ID: 345414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins and vagal stimulation of gastric secretion in duodenal ulcer patients.
    Konturek SJ; Kwiecień N; Obtułowicz W; Oleksy J
    Scand J Gastroenterol; 1983 Jan; 18(1):43-7. PubMed ID: 6426038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion.
    Wilson DE; Winnan G; Quertermus J; Tao P
    Gastroenterology; 1975 Sep; 69(3):607-11. PubMed ID: 1158077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical effects of 16,16 dimethyl prostaglandin E2 on gastric acid secretion and mucosal permeability to hydrogen ions in dogs.
    Cheung LY; Lowry SF; Perry J; Larson K
    Gut; 1978 Sep; 19(9):775-8. PubMed ID: 30680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 16,16-dimethyl prostaglandin-E2 given intra-arterially or intra-gastrically, on acid secretion by canine stomachs perfused ex vivo.
    Kowalewski K; Kolodej A
    Prostaglandins; 1978 May; 15(5):901-6. PubMed ID: 704913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric antisecretory activity of arbaprostil as affected by gastric pH.
    Reele SB
    Dig Dis Sci; 1985 Jul; 30(7):612-6. PubMed ID: 4006643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nocturnal gastric secretion by trimoprostil, a synthetic prostanoid.
    Penston J; Johnston DA; Wilson JA; Wormsley KG
    Curr Med Res Opin; 1986; 10(3):145-9. PubMed ID: 3089691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 and gastric acid secretion in man.
    Bennett A; Stamford IF; Unger WG
    J Physiol; 1973 Mar; 229(2):349-60. PubMed ID: 4198992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.
    Karim SM; Carter DC; Bhana D; Ganesan PA
    Br Med J; 1973 Jan; 1(5846):143-6. PubMed ID: 4706806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man.
    Caldara R; Guslandi M; Carbone M; Masci E; Cantù A; Ferrari C; Barbieri C; Dubini A
    Eur J Clin Pharmacol; 1987; 31(5):535-9. PubMed ID: 3830240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of graded 15(R)15 methyl prostaglandin E2 and of indomethacin on the gastric secretory and plasma gastrin response to modified shamfeeding.
    Johansson C; Befrits R; Wisén O; Kallner A
    Acta Physiol Scand; 1984 Nov; 122(3):421-6. PubMed ID: 6516889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.